November 27, 2018

A new promising cancer drug may have saved this 9-year-old’s life and holds promise for thousands more

A cancer drug newly approved by the FDA could help thousands of people every year and it's already giving hope to a family who thought they were out of options for their 9-year-old son. At age 5, Ashton Leeds was diagnosed with stage 4 thyroid cancer. After his cancer became resistant to treatment, Ashton joined a trial for a cutting-edge drug called larotrectinib that targets a specific genetic mutation found in certain kinds of cancers.
November 13, 2018

Living past leukemia: Survivorship and lasting side effects

When cancer therapy is over, patients should obtain a copy of their treatment summary and schedule an appointment with a survivorship clinic.
November 8, 2018

New “multi-omic” research projects launched to confront the complexity of glioblastoma and pediatric brain tumor treatment development

The National Cancer Institute announced funding totaling $4 million for new adult and pediatric brain cancer research projects. Project HOPE (High-Grade Glioma-Omics in Pediatric and AYA) will use single-cell sequencing approaches designed to capture critical information on tumor cell types and the tumor microenvironment that are missed by traditional sequencing techniques.
November 6, 2018

Napavine Restaurant Manager Shaves Head To Support Local Boy Diagnosed With Leukemia

Over the summer, 2-year-old Björn Roth was diagnosed with B-cell acute lymphoblastic leukemia. He is currently at Seattle Children’s Hospital for a chimeric antigen receptor study (CAR-T trial).